Advertisement
HIMS vs IPAR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIMS is a Hold and IPAR is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HIMS’s FA Score shows that 0 FA rating(s) are green whileIPAR’s FA Score has 1 green FA rating(s).
- HIMS’s FA Score: 0 green, 5 red.
- IPAR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HIMS’s TA Score shows that 2 TA indicator(s) are bullish while IPAR’s TA Score has 6 bullish TA indicator(s).
- HIMS’s TA Score: 2 bullish, 5 bearish.
- IPAR’s TA Score: 6 bullish, 3 bearish.
Price Growth
HIMS (@Pharmaceuticals: Generic) experienced а -10.19% price change this week, while IPAR (@Household/Personal Care) price change was -2.15% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.88%. For the same industry, the average monthly price growth was +0.21%, and the average quarterly price growth was +13.40%.
The average weekly price growth across all stocks in the @Household/Personal Care industry was -2.96%. For the same industry, the average monthly price growth was -0.40%, and the average quarterly price growth was -7.17%.
Reported Earning Dates
HIMS is expected to report earnings on Aug 10, 2026.
IPAR is expected to report earnings on Aug 11, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-3.88% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
@Household/Personal Care (-2.96% weekly)Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.
| HIMS | IPAR | HIMS / IPAR | |
| Capitalization | 7.96B | 3.8B | 210% |
| EBITDA | 37.6M | 305M | 12% |
| Gain YTD | 5.882 | 42.004 | 14% |
| P/E Ratio | 57.14 | 22.50 | 254% |
| Revenue | 2.37B | 1.5B | 159% |
| Total Cash | 751M | N/A | - |
| Total Debt | 1.13B | 183M | 619% |
HIMS | IPAR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 75 | 45 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 80 Overvalued | 25 Undervalued | |
PROFIT vs RISK RATING 1..100 | 76 | 58 | |
SMR RATING 1..100 | 93 | 45 | |
PRICE GROWTH RATING 1..100 | 39 | 40 | |
P/E GROWTH RATING 1..100 | 81 | 65 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IPAR's Valuation (25) in the Household Or Personal Care industry is somewhat better than the same rating for HIMS (80) in the null industry. This means that IPAR’s stock grew somewhat faster than HIMS’s over the last 12 months.
IPAR's Profit vs Risk Rating (58) in the Household Or Personal Care industry is in the same range as HIMS (76) in the null industry. This means that IPAR’s stock grew similarly to HIMS’s over the last 12 months.
IPAR's SMR Rating (45) in the Household Or Personal Care industry is somewhat better than the same rating for HIMS (93) in the null industry. This means that IPAR’s stock grew somewhat faster than HIMS’s over the last 12 months.
HIMS's Price Growth Rating (39) in the null industry is in the same range as IPAR (40) in the Household Or Personal Care industry. This means that HIMS’s stock grew similarly to IPAR’s over the last 12 months.
IPAR's P/E Growth Rating (65) in the Household Or Personal Care industry is in the same range as HIMS (81) in the null industry. This means that IPAR’s stock grew similarly to HIMS’s over the last 12 months.
| HIMS | IPAR | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 76% | 1 day ago 64% |
| Stochastic ODDS (%) | 1 day ago 87% | 1 day ago 66% |
| Momentum ODDS (%) | N/A | 1 day ago 65% |
| MACD ODDS (%) | 1 day ago 78% | 4 days ago 74% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 66% |
| TrendMonth ODDS (%) | 1 day ago 86% | 1 day ago 70% |
| Advances ODDS (%) | 13 days ago 87% | 4 days ago 72% |
| Declines ODDS (%) | 4 days ago 81% | N/A |
| BollingerBands ODDS (%) | 1 day ago 88% | 1 day ago 63% |
| Aroon ODDS (%) | 1 day ago 86% | 1 day ago 71% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VCV | 10.87 | 0.04 | +0.37% |
| INVESCO CALIFORNIA VALUE MUNI Income TRUST | |||
| FGM | 62.89 | N/A | N/A |
| First Trust Germany AlphaDEX® ETF | |||
| BU | 18.17 | N/A | N/A |
| Defiance Daily Target 2X Long BU ETF | |||
| JNEU | 33.16 | -0.17 | -0.50% |
| AllianzIM U.S. Equity Buffer15 UncJunETF | |||
| XAR | 264.17 | -7.28 | -2.68% |
| Stt Strt® SPDR® S&P® Arspc & Dfnc ETF | |||
HIMS and
Correlation & Price change
A.I.dvisor tells us that HIMS and COTY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIMS and COTY's prices will move in lockstep.
| Ticker / NAME | Correlation To HIMS | 1D Price Change % | ||
|---|---|---|---|---|
| HIMS | 100% | N/A | ||
| COTY - HIMS | 31% Poorly correlated | N/A | ||
| EVO - HIMS | 24% Poorly correlated | -12.75% | ||
| AMLX - HIMS | 24% Poorly correlated | -2.03% | ||
| IPAR - HIMS | 24% Poorly correlated | -0.68% | ||
| AQST - HIMS | 23% Poorly correlated | -1.46% | ||
More | ||||